Supported by
Education Partner
Training Partner
Latest News & Press
Top Trio back 1st MDS with liquids and tablets...
Three big names from the pharmacy and care home fields have thrown their support behind a revolutionary new monitored dosage system.
All have joined the board of Protomed, the hi-tech British design company that has created Biodose - first regime in the world to allow same-tray dispensing of liquids and tablets.
They are Steve Dunn, ex-group managing director of AAH Pharmaceuticals and a former chairman of the BAPW, Tony Heywood, ex-chief executive of Four Seasons Health Care and Westminster Health Care and chairman of the English Community Care Association, and Tim Street, who held board level positions with Four Seasons and Westminster.
Heywood joins as company chairman and Dunn and Street as non-executive directors.
Protomed chief executive Norman Niven says pilots in Ireland have gone "fantastically well" and the company is now in full production mode to expand into the UK. "We are currently in the process of seeking partners such as pharmacy and care home groups to help us take the product forward, and we think they will find the faith in Biodose shown by three such respected names convincing and reassuring. "They are all prominent players within their fields and all have been highly impressed by Biodose, see a great need for it, and want to be associated with it."
Integral to the system is unique anti-microbial technology that effectively combats the transfer of MRSA and other infections. As well as allowing the simultaneous unit-dose dispensing of liquids and tablets it also monitors and manages external preparations, making it the world's first total medicines management system - or ToMM, as Protomed has trademarked it.Dunn forecasts Biodose will change community pharmacists' mindset on MDS and make all other medication regimes redundant because it has exceptional business and professional advantages. "In commercial terms pharmacists can enhance profit by providing a better offer, something care homes have been crying out for. "I'm talking of an MDS system that permits safe dispensing and monitoring of liquids and solids together, has high anti-infective qualities, and also produces the management reports that care homes are obliged to provide. "In clinical terms it allows pharmacists to perform the primary service for which they exist - dispensing and medicines management - more efficiently, effectively and safely, while at the same time putting them at the front line of infection control."
Niven, a former owner-manager pharmacist and ex-director and board member of BUPA Care Services, adds: "Any community pharmacy wanting to protect and build its care home business needs to embrace Biodose. "Furthermore we see the partnership of pharmacies and care homes working together as crucial to the fight against MRSA."
Biodose had an unveiling at the British Pharmacy Congress in early September and is to be aired at the Pharmacy Show in October and the Care Show in November.
